Multiple Myeloma public [search 0]
×
Join millions of Player FM users today to get news and insights whenever you like, even when you're offline. Podcast smarter with the free podcast app that refuses to compromise. Let's play!
Join the world's best podcast app to manage your favorite shows online and play them offline on our Android and iOS apps. It's free and easy!
More
show episodes
 
C
CureTalks
Monthly
 
CureTalks features leading medical experts in conversation with a panel of patients/advocates about latest research and treatments under development.
 
Myeloma Crowd Radio brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
 
The Multiple Myeloma Research Foundation provides educational programs to help people with myeloma, family members, caregivers, and healthcare professionals learn more about the disease and today's most promising treatment options, including clinical trials, from leading multiple myeloma doctors and researchers.
 
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
 
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
 
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
 
O
OncLive® On Air
Weekly
 
In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.
 
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
 
'Bolus: education delivered stat' is a podcast exploring the Haematology speciality, created for nurses, junior doctors and allied healthcare professionals. It is made by three UCLH Haematology nurses, Sonia Thomas and Sarah Jordan, both ward sisters, and Gavin Cooper, a nurse educator. We will be releasing a new episode every Monday.
 
PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
 
PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
 
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
 
PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
 
How do you truly connect with others and lead with empathy? Why is heart disease different for women? What can we do to make addiction treatment more accessible and more successful? How can you maintain the balance between rising in your field and taking care of your family? Charged, a new podcast from Mass General, is devoted to answering these questions and many more. We’ll be uncovering the stories of the relentless daily pursuit to break boundaries and provide exceptional care. In each e ...
 
DOG TALK® (and Kitties, Too!) features Tracie’s interviews with authors and pet experts from around the world, discussing far-ranging topics involving dogs and cats, many with dog health information, dog and puppy training advice, and help in living harmoniously with your cat.This Gracie® Award-winning show, produced and hosted by pet wellness advocate Tracie Hotchner, has been broadcasting for 13 years with more than 620 consecutive shows from its originating NPR station Peconic Public Broa ...
 
PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
 
PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
 
PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
 
Healthcare Triage is a series about healthcare hosted by Dr. Aaron Carroll who explains healthcare policy, medical research, and answers a lot of other questions you may have about medicine, health, and healthcare.
 
Dr. Mikkael Sekeres will cover important issues related to Myelodysplastic Syndromes in the format of case-study scenarios
 
G
Grand Rounds Nation
Monthly
 
Grand Rounds, a staple of American medical education for more than 100 years, spans every field of clinical practice. It is a master class on the art and science of medicine, delivered by renowned clinicians in academic settings nationwide. Yet in today's practice, where time is an all-too precious commodity, regular attendance at Grand Rounds sessions has become increasingly difficult. In response to this challenge, ReachMD brings the lecture hall to you, with these outstanding talks from t ...
 
O
OT Broadcast News
Monthly
 
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992.Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on t ...
 
V
VJHemOnc Podcast
Monthly
 
The video journal of hematological oncology
 
Loading …
show series
 
Multiple myeloma is a heterogenous plasma cell disorder that contains a small fraction of clonogenic stem cells, just like many other cancers. Although the exact nature and biological properties of these cells remain elusive, multiple myeloma stem cells (MMSCs) have pronounced drug resistance and are believed to be the root cause of failure of ...…
 
Dr. Elsey's #CatsAgainstCancer Campaign to Fund Mulitple Myeloma Research Foundation; Clive Wynn (Dog Is Love) on human-canine bond; Gary Weitzman (Complete Guide to Pet Health, Behavior and Happiness)By Tracie Hotchner.
 
Paving the Way to Better Outcomes in EGFR-Mutant NSCLC: Time to Take a Step Further?By PeerVoice.
 
Paving the Way to Better Outcomes in EGFR-Mutant NSCLC: Time to Take a Step Further?By PeerVoice.
 
Jane L. Meisel, MD, and Aditya Bardia, MD, MPH, shed light on treatment considerations for women with triple-negative breast cancer (TNBC) who are candidates for neoadjuvant therapy, emerging treatment strategies for patients with metastatic TNBC, as well as the optimal timing of genomic testing in women with progressive hormone receptor–positi ...…
 
As a medical student, the last thing Dr. Cristina Ferrone thought she would ever become was a surgeon, as the male-dominated specialty forced the few women in it to make hard lifestyle choices. However, when she entered her surgical rotation, she was surprised to discover how much she loved it. She is now a leader in pancreatic cancer and bile ...…
 
Dr Magdalena Dziadzio kindly joins us to discuss all things immunity. She discusses the organs, tissues, proteins and cells that when combined, protect us from infection and cancer. We gain insight into how B-cell and T-cell lymphocytes work together in the thymus to develop antibodies that give our immune system memory. We then proceed onto di ...…
 
Is there a problem with purposely cross-breeding purebred dogs? The Mutual Rescue documentary “Keema & Her Pack”; a woman's life enriched by catsBy Tracie Hotchner.
 
Recognizing and Addressing Immune-Related Adverse Events: Key Strategies to Optimize Patient Outcomes With ImmunotherapyBy PeerVoice.
 
Breast cancer is the second most common cancer in women (although men can get it too). Some breast cancers are driven by inherited mutations while most are sporadic, driven by unknown causes or by environmental or behavioral factors like obesity, lack of exercise, or alcohol use. Breast cancer screening aims to reduce the number of women who di ...…
 
We recently traveled to Seattle, California for a State of the Science Summit™ on Hematologic Malignancies. At the meeting, faculty from Seattle Cancer Care Alliance provided insight on current and evolving standards of care in leukemia, lymphoma, and myeloma, highlighting particular targets of interest for novel therapies.…
 
In this episode we explore the slightly less common acute leukaemia sub-type, Acute Lymphoblastic Leukaemia (ALL). Prof Adele Fielding takes us through many technical questions, why is ALL a disease seen predominantly in the young, why does it require years of maintenance therapy unlike AML, how is it diagnosed and graded, can ALL be considered ...…
 
Kitten Lady Hannah Shaw on caring for smallest, fragile kittens; Vancouver's quirky dog-centric lifestyles; veterinarian visits remote Alaska villages by boatBy Tracie Hotchner.
 
We recently traveled to Milwaukee, Wisconsin, for a State of the Science Summit™ on Breast Cancer. At the meeting, faculty from Carbone Cancer Center of the University of Wisconsin highlighted the evolving paradigms across breast cancer subtypes and settings, such as early and advanced hormone receptor–positive breast cancer, early-stage HER2-p ...…
 
Aaron talks to Dr. Tatiana Foroud about her career and her current work in genetics and genomics. Her work spans from the early days of searching for DNA markers for rare disorders to today's search for genetic causes and potential treatments around Alzheimer's disease. Dr. Foroud's career relates a story about how the technology and techniques ...…
 
Aaron talks to Dr. Tatiana Foroud about her career and her current work in genetics and genomics. Her work spans from the early days of searching for DNA markers for rare disorders to today's search for genetic causes and potential treatments around Alzheimer's disease. Dr. Foroud's career relates a story about how the technology and techniques ...…
 
Go online to PeerView.com/ZJH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in eosinophilic granulomatosis with polyangiitis (EGPA) discuss the pathophysiology and diagnosis of EGPA, as well as strategies for treatment and the impact on patient quality of life. A ...…
 
Go online to PeerView.com/ZJH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in eosinophilic granulomatosis with polyangiitis (EGPA) discuss the pathophysiology and diagnosis of EGPA, as well as strategies for treatment and the impact on patient quality of life. A ...…
 
A presentation on non-small cell lung cancer featuring perspectives from Dr Matthew Gubens. Introduction (00:00) Evolving Paradigms for Patients with Non-Small Cell Lung Cancer (NSCLC) and EGFR Tumor Mutations (01:12) Immune Checkpoint Inhibition for Patients with Locally Advanced NSCLC (19:27) Recently Approved and Investigational Immunotherap ...…
 
A presentation on non-small cell lung cancer featuring perspectives from Dr Matthew Gubens. Introduction (00:00) Evolving Paradigms for Patients with Non-Small Cell Lung Cancer (NSCLC) and EGFR Tumor Mutations (01:12) Immune Checkpoint Inhibition for Patients with Locally Advanced NSCLC (19:27) Recently Approved and Investigational Immunotherap ...…
 
A presentation on non-small cell lung cancer featuring perspectives from Dr Matthew Gubens. Introduction (00:00) Evolving Paradigms for Patients with Non-Small Cell Lung Cancer (NSCLC) and EGFR Tumor Mutations (01:12) Immune Checkpoint Inhibition for Patients with Locally Advanced NSCLC (19:27) Recently Approved and Investigational Immunotherap ...…
 
A presentation on non-small cell lung cancer featuring perspectives from Dr Matthew Gubens. Introduction (00:00) Evolving Paradigms for Patients with Non-Small Cell Lung Cancer (NSCLC) and EGFR Tumor Mutations (01:12) Immune Checkpoint Inhibition for Patients with Locally Advanced NSCLC (19:27) Recently Approved and Investigational Immunotherap ...…
 
Cellectar Biosciences is working on testing a radiosensitive therapy in blood cancers including multiple myeloma. Their product, CLR 131, targets the myeloma tumors by delivering a cytotoxic radioisotope, iodine-131 directly to the tumor cells. Phase I study results showed an overall mean survival rate of 26.2 months for relapsed/refractory mye ...…
 
Go online to PeerView.com/HMF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert endocrinologist discusses the use of basal insulin therapy to manage patients with type 2 diabetes mellitus (T2DM), focusing on identifying patients who should receive insulin, overcomi ...…
 
Go online to PeerView.com/HMF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert endocrinologist discusses the use of basal insulin therapy to manage patients with type 2 diabetes mellitus (T2DM), focusing on identifying patients who should receive insulin, overcomi ...…
 
Go online to PeerView.com/ZVS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, a hematologist/oncologist and a nurse professional discuss the characteristics and management of secondary AML, with an emphasis on practical aspects of care and the use of novel therapy. This mu ...…
 
Go online to PeerView.com/ZVS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, a hematologist/oncologist and a nurse professional discuss the characteristics and management of secondary AML, with an emphasis on practical aspects of care and the use of novel therapy. This mu ...…
 
Go online to PeerView.com/ZVS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, a hematologist/oncologist and a nurse professional discuss the characteristics and management of secondary AML, with an emphasis on practical aspects of care and the use of novel therapy. This mu ...…
 
Go online to PeerView.com/ZVS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, a hematologist/oncologist and a nurse professional discuss the characteristics and management of secondary AML, with an emphasis on practical aspects of care and the use of novel therapy. This mu ...…
 
Go online to PeerView.com/ZVS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, a hematologist/oncologist and a nurse professional discuss the characteristics and management of secondary AML, with an emphasis on practical aspects of care and the use of novel therapy. This mu ...…
 
Go online to PeerView.com/ZVS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, a hematologist/oncologist and a nurse professional discuss the characteristics and management of secondary AML, with an emphasis on practical aspects of care and the use of novel therapy. This mu ...…
 
Chronic Lymphocytic Lymphoma, Issue 2, 2019 — Part 1: Our interview with Prof Stilgenbauer highlights the following topics as well as cases from his practice: Updated International Workshop on Chronic Lymphocytic Leukemia guidelines for diagnosis, indications for treatment, response assessment and management of chronic lymphocytic leukemia (CLL ...…
 
Chronic Lymphocytic Lymphoma, Issue 2, 2019 — Part 1: Our interview with Prof Stilgenbauer highlights the following topics as well as cases from his practice: Updated International Workshop on Chronic Lymphocytic Leukemia guidelines for diagnosis, indications for treatment, response assessment and management of chronic lymphocytic leukemia (CLL ...…
 
Chronic Lymphocytic Lymphoma, Issue 2, 2019 — Part 1: Our interview with Prof Stilgenbauer highlights the following topics as well as cases from his practice: Updated International Workshop on Chronic Lymphocytic Leukemia guidelines for diagnosis, indications for treatment, response assessment and management of chronic lymphocytic leukemia (CLL ...…
 
Chronic Lymphocytic Lymphoma, Issue 2, 2019 — Part 1: Our interview with Prof Stilgenbauer highlights the following topics as well as cases from his practice: Updated International Workshop on Chronic Lymphocytic Leukemia guidelines for diagnosis, indications for treatment, response assessment and management of chronic lymphocytic leukemia (CLL ...…
 
Chronic Lymphocytic Lymphoma, Issue 2, 2019 — Part 2: Our interview with Dr Woyach highlights the following topics as well as cases from her practice: Recent data and evolution of the front-line treatment paradigm for patients with CLL (00:00) Evaluation of MRD and implications for therapy (03:50) Efficacy and tolerability of first-line regimen ...…
 
Chronic Lymphocytic Lymphoma, Issue 2, 2019 — Part 2: Our interview with Dr Woyach highlights the following topics as well as cases from her practice: Recent data and evolution of the front-line treatment paradigm for patients with CLL (00:00) Evaluation of MRD and implications for therapy (03:50) Efficacy and tolerability of first-line regimen ...…
 
Chronic Lymphocytic Lymphoma, Issue 2, 2019 — Part 2: Our interview with Dr Woyach highlights the following topics as well as cases from her practice: Recent data and evolution of the front-line treatment paradigm for patients with CLL (00:00) Evaluation of MRD and implications for therapy (03:50) Efficacy and tolerability of first-line regimen ...…
 
Chronic Lymphocytic Lymphoma, Issue 2, 2019 — Part 2: Our interview with Dr Woyach highlights the following topics as well as cases from her practice: Recent data and evolution of the front-line treatment paradigm for patients with CLL (00:00) Evaluation of MRD and implications for therapy (03:50) Efficacy and tolerability of first-line regimen ...…
 
Chronic Lymphocytic Leukemia Update - Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Professor Dr Stephan Stilgenbauer conducted by Neil Love, MD. Produced by Research To Practice.
 
Chronic Lymphocytic Leukemia Update - Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Jennifer Woyach, MD conducted by Neil Love, MD. Produced by Research To Practice.
 
September is National Recovery Month. This month has two goals: to increase awareness and understanding of mental and substance use disorders. And to celebrate the people in recovery. In honor of the month, we are bringing back this episode from season one with Dr. Sarah Wakeman, an addiction medicine specialist and the medical director of the ...…
 
We recently traveled to Pasadena, California, for a State of the Science Summit™ on Ovarian Cancer. At the meeting, faculty from City of Hope discussed the necessity of genetic testing as well as the latest data regarding the use of PARP inhibitors, immunotherapy, chemotherapy, and surgical debulking while explaining how these data can be inter ...…
 
In Episode 6 we are joined by Stephen Rowley, the senior nurse for Haematology at UCLH and the originator of Aseptic Non-Touch Technique (ANTT). Our conversation covers the role of standardisation in improving standards, the importance of having a common language when discussing asepsis, and ultimately how he has helped develop and spread the i ...…
 
Cat Film Fest Preview: A Life Depicted Through Siamese Cats; a mass photoshoot (and adoption event) of dogs in Los Angeles shelters; Laurien Berenson (Bite Club)By Tracie Hotchner.
 
Recent clinical trials studying novel therapeutic strategies to target chronic lymphocytic leukemia (CLL) have brought a spotlight to their potential as alternatives to traditional chemotherapy. Here we bring you an overview and discussion on the latest trial updates, including CLL12, CLL14, RESONATE, ASCEND, among others. This podcast features ...…
 
Maha Hussain, MD, FACP, FASCO, of Northwestern University Feinberg School of Medicine, reflected on the path that led her into genitourinary cancers.By OncLive® On Air.
 
Google login Twitter login Classic login